Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 · New England Journal of Medicine · 4,543 citations
https://doi.org/10.1056/nejmoa040766
J
James M. Reuben
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
431
Papers
22.6K
Citations
72
h-index
189
i10-index
James M. Reuben is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer Cells and Metastasis & Cancer Immunotherapy and Biomarkers & Cancer Treatment and Pharmacology. The author has an h-index of 72, co-authored 367 publications.
ORCID: 0000-0001-8972-2103Papers by this author
worksPhase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer
2017 · Clinical Cancer Research · 236 citations
https://doi.org/10.1158/1078-0432.ccr-16-2748
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
2011 · Breast Cancer Research · 224 citations
https://doi.org/10.1186/bcr2907
Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
2012 · Molecular Cancer Therapeutics · 223 citations
https://doi.org/10.1158/1535-7163.mct-12-0460
Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
2013 · Clinical Cancer Research · 180 citations
https://doi.org/10.1158/1078-0432.ccr-12-2549
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
2013 · Annals of Oncology · 138 citations
https://doi.org/10.1093/annonc/mdt525
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat